ALR Technologies
ALR Technologies is a data management company focused on diabetes care and animal health solutions. They develop innovative, FDA-cleared, HIPAA-compliant systems that collect and analyze health data to improve patient outcomes and contain healthcare costs. Their mission is to enhance chronic healthcare management through active patient management, leveraging AI, and expanding services to other chronic diseases.
Industries
Nr. of Employees
small (1-50)
ALR Technologies
7400 Beaufont Springs Drive, Suite 300, Richmond VA 23225, USA
Products
Cloud-based diabetes management platform (FDA-cleared components)
A cloud platform that collects glucose device data, calculates predictive A1C, provides AI-assisted insulin dosing suggestions, and supplies a clinician console for population management; described as FDA-cleared for certain components and HIPAA-compliant.
Pet continuous glucose monitoring system with veterinarian portal
A continuous glucose monitor packaged for cats and dogs that records frequent home-based glucose readings (data points every ~3 minutes, up to ~480/day) and uploads to a veterinarian-facing portal that visualizes curves and offers insulin dosing suggestions.
Patient mobile app and starter glucose meter offering
Patient-facing mobile application for uploading glucose tests and starter meter packages (meter, strips, lancets) to enable participation in remote monitoring programs.
Cloud-based diabetes management platform (FDA-cleared components)
A cloud platform that collects glucose device data, calculates predictive A1C, provides AI-assisted insulin dosing suggestions, and supplies a clinician console for population management; described as FDA-cleared for certain components and HIPAA-compliant.
Pet continuous glucose monitoring system with veterinarian portal
A continuous glucose monitor packaged for cats and dogs that records frequent home-based glucose readings (data points every ~3 minutes, up to ~480/day) and uploads to a veterinarian-facing portal that visualizes curves and offers insulin dosing suggestions.
Patient mobile app and starter glucose meter offering
Patient-facing mobile application for uploading glucose tests and starter meter packages (meter, strips, lancets) to enable participation in remote monitoring programs.
Services
Ongoing remote monitoring service that uses a clinician console and trained facilitators to review glucose data, flag out-of-range cases, and coordinate clinician interventions.
Services to implement the diabetes management platform within provider organizations, including onboarding, workflow integration, and account management.
Establishment and management of contract manufacturing agreements to produce CGM hardware and associated devices.
Ongoing remote monitoring service that uses a clinician console and trained facilitators to review glucose data, flag out-of-range cases, and coordinate clinician interventions.
Services to implement the diabetes management platform within provider organizations, including onboarding, workflow integration, and account management.
Establishment and management of contract manufacturing agreements to produce CGM hardware and associated devices.
Expertise Areas
- Remote patient monitoring for diabetes
- AI-driven clinical decision support for insulin therapy
- Predictive biomarker algorithms (predictive A1C)
- Veterinary glucose monitoring and pet CGM commercialization
Key Technologies
- Continuous glucose monitoring (CGM)
- Blood glucose meter data ingestion
- Predictive A1C algorithms
- AI-based insulin dosing algorithms
News & Updates
ALRT announced a manufacturing agreement with CGM Medical Technology Shen Zhen Ltd. in China to supply hardware for the GluCurve Pet CGM.
ALRT announced a patent grant for its Predictive A1C algorithm and shared successful results from a study led by Singapore General Hospital.
ALRT announced plans to launch the GluCurve Pet CGM in Canada during Q3 2023 through a direct-to-veterinarian sales model.
ALRT announced a manufacturing agreement with CGM Medical Technology Shen Zhen Ltd. in China to supply hardware for the GluCurve Pet CGM.
ALRT announced a patent grant for its Predictive A1C algorithm and shared successful results from a study led by Singapore General Hospital.
ALRT announced plans to launch the GluCurve Pet CGM in Canada during Q3 2023 through a direct-to-veterinarian sales model.